# Kangjun Capital

> Kangjun Capital is a VC fund in Beijing backing Health Care, Medical and Biopharma. See 16 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 16
- Last investment: Aug 2026
- Lead investor: 50%
- Last updated: Aug 2026

Kangjun Capital is a investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 44% |
| Medical | 6 | 38% |
| Biopharma | 5 | 31% |
| Biotechnology | 5 | 31% |
| Pharmaceutical | 4 | 25% |

19 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 6 | 38% |
| Seed | 3 | 19% |
| Series C | 3 | 19% |
| Series B | 2 | 13% |
| Angel | 1 | 6% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 13 | 81% |
| United States | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ommo Technologies | Making computing more human and effortless. Sensor based position tracking technology using a patented permanent magnet approach. |  | Series A | Aug 07, 2026 |  |
| Deepin Technology | Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue. |  | Series A | Jul 14, 2026 |  |
| Logicbit Technology | Logic Bit is a developer of large-scale superconducting quantum computing devices. Logic Bit has established technological reserves that encompass the full process of superconducting quantum chip design, micro-nano processing, radio frequency control, quantum computation, and simulation. |  | Series A | Jul 09, 2026 |  |
| BrainThink Technology | BrainThink Technology is a high-tech enterprise specializing in the research and development of brain-computer interface (BCI) technology. | $10M | Angel | May 18, 2026 |  |
| Mesai Biotech | Mesai Biotech is a macromolecule drug developer, focusing on the development of new macrophage targets in the tumor immune microenvironment. | $21.8M | Series A | Apr 02, 2026 |  |
| Rigerna | Rigerna develops unique small nucleic acid medicines and innovative nucleic acid therapies for nonliver tissues. | $29M | Seed | Mar 20, 2026 |  |
| Logicbit Technology | Logic Bit is a developer of large-scale superconducting quantum computing devices. Logic Bit has established technological reserves that encompass the full process of superconducting quantum chip design, micro-nano processing, radio frequency control, quantum computation, and simulation. |  | Seed | Mar 17, 2026 |  |
| Deepin Medical | Deepin Medical is dedicated to developing intelligent gadgets that address all aspects of surgery under a microscope. |  | Series A | Feb 03, 2026 |  |
| Jiajin Biotech | Jiajin Biotech is a pharmaceutical R&D service provider. It specializes in the development of antibody-small nucleic acid conjugates. |  | Series B | Dec 29, 2025 |  |
| Danking Pharmaceuticals | Danking Medicine is an innovation-driven drug developer. | $20.6M | Seed | Mar 03, 2025 |  |

10 of 16 investments shown.

## Co-investors
- [Tsinghua Holdings Capital](https://shizune.co/investors/profile/tsinghua-holdings-capital) — VC Fund, 3 deals together
- [AstraZeneca CICC Medical Industry Fund](https://shizune.co/investors/profile/astrazeneca-cicc-medical-industry-fund) — VC Fund, 2 deals together
- [Bayland Capital](https://shizune.co/investors/profile/bayland-capital) — VC Fund, 2 deals together
- [Dongfang Jiafu](https://shizune.co/investors/profile/dongfang-jiafu) — VC Fund, 2 deals together
- [Fortune Venture Capital](https://shizune.co/investors/profile/fortune-venture-capital) — VC Fund, 2 deals together
- Huaxia Heng Tian — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Kangjun Capital invest in?

Kangjun Capital invests primarily in Health Care, Medical and Biopharma startups, most often at Series A and Seed stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Kangjun Capital last invest?

The most recent investment recorded for Kangjun Capital closed in Aug 2026. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co